GleamWall
中文EN

FCHS First Choice Healthcare Solutions, Inc.

Services-Medical Laboratories · OTC · SEC CIK 1416876 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-552.3%
TTM EPS YoY-518.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets657.7%
Debt / equity—
Current ratio0.01x
Interest coverage-0.14x

Cash quality & payout

Operating cash flow / net income0.12x
Accruals ratio-645.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
Gross profit$7,350—
SG&A expense$1.88M$906,815
Operating income-$2.67M-$1.29M
Interest expense$4.71M$3.35M
Pretax income-$6.96M-$3.74M
Income tax—$111,950
Net income-$6.96M-$3.85M
EBITDA-$2.65M-$1.25M
EPS (basic)—-0.12
EPS (diluted)-0.21-0.12
Weighted avg. shares (diluted)32.96M32.96M
Balance sheet
Cash & equivalents$5,896$19,915
Receivables$717$72,270
Current assets$6,613$92,185
PP&E, net$146,961$222,816
Total assets$4.05M$4.51M
Current liabilities$40.67M$33.27M
Total liabilities$43.58M$36.98M
Shareholders' equity-$39.53M-$32.47M
Shares outstanding32.96M32.96M
Cash flow statement
Operating cash flow-$549,019-$1.71M
Investing cash flow$10,000$7,000
Financing cash flow$525,000$1.71M
Depreciation & amortization$17,527$34,569

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.